Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-06-14
2005-06-14
Saeed, Kamal (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C549S432000
Reexamination Certificate
active
06906101
ABSTRACT:
A novel taxane derivative with anticancer activity, a process for its preparation and a process for the preparation of 14-β-hydroxy-1,14-carbonate-baccatine III and V derivatives 13-substituted by an isoserine residue.
REFERENCES:
patent: 5476954 (1995-12-01), Bourzat et al.
patent: 5621121 (1997-04-01), Commercon et al.
patent: 5705508 (1998-01-01), Ojima et al.
patent: 5750562 (1998-05-01), Bombardelli et al.
patent: 5763628 (1998-06-01), Bourzat et al.
G. Appendino et al., “Synthesis and Evaluation of C-seco-Paclitaxel Analogues”, Tetrahedron Letters, vol. 38, No. 24, 1997, pp. 4273-4276.
I. Ojiwa et al., “Synthesis and Structure-Activity Relationships of Taxoids Derived From 14-beta-Hydroxy-10-deacetylbaccatin III”,Journal of Chemistry, vol. 40, No. 2, Jan. 17, 1997, pp. 267-278.
Bombardelli Ezio
Gabetta Bruno
Pontiroli Alessandro
Indena S.p.A.
Jones Day
Saeed Kamal
LandOfFree
Taxane derivatives and processes for the preparation thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Taxane derivatives and processes for the preparation thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Taxane derivatives and processes for the preparation thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3478843